ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1605

Enhanced Oxidant Signaling in Inflammatory Macrophages in Rheumatoid Arthritis (RA) and in Coronary Artery Disease (CAD)

Tsuyoshi Shirai1, Benedikt Schaefgen1, Barbara Wallis1, Eric L. Matteson2, Themistocles L. Assimes3, David G. Harrison4, Jorg Goronzy5 and Cornelia M. Weyand6, 1Medicine: Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 2Rheumatology, Mayo Clinic, Rochester, MN, 3Stanford University School of Medicine, Stanford, CA, 4Clinical Pharmacology, Vanderbilt University School of Medicine, Nashville, TN, 5Medicine/Division of Immunology & Rheumatology, Stanford University School of Medicine, Stanford, CA, 6Medicine, Stanford University School of Medicine, Stanford, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: coronary artery disease, macrophages and rheumatoid arthritis (RA)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 9, 2015

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: RA patients have a 2-fold increased risk of developing coronary artery disease (CAD) regardless of traditional risk factors. Atherosclerosis, the underlying process in CAD, is a chronic maladaptive inflammatory response, and macrophages play a critical role in its progression through cytokine and chemokine secretion, production of tissue-injurious enzymes and amplification of adaptive immune responses. Here, we have examined macrophages in RA and CAD, with the goal to identify disease-specific and shared molecular pathways swaying such myeloid cells towards pathogenic inflammation.

Methods: Patients with RA who fulfilled 2010 ACR/EULAR RA Classification Criteria, CAD patients with a history of at least one myocardial infarction (>3 months post event), and healthy controls were enrolled. Monocytes isolated from peripheral blood were differentiated into macrophages with macrophage colony stimulating factor. To recapitulate an inflammatory tissue environment, macrophages were stimulated with IFN-γ and lipopolysaccharide. Gene expression profiles were analyzed by quantitative RT-PCR. Intracellular cytokines were measured by flow cytometry. Intracellular reactive oxygen species (ROS) were quantified using CellROX. The oxidant superoxide was scavenged using the superoxide dismutase mimetic, Tempol.

Results: Compared to healthy macrophages, RA and CAD macrophages shared the enhanced expression of the oxidative stress response gene, NAD(P)H:quinone oxidoreductase 1 (NQO1). Measurements with redox-sensitive probes confirmed an oversupply of reactive oxidant species. Also, RA and CAD macrophages were programmed to produce higher levels of the chemokine CCL18, which promotes T cell recruitment and is highly expressed in the atherosclerotic plaque. Scavenging of ROS with Tempol suppressed CCL18 production, implicating oxidant species in regulating the chemokine secretion profile. Depriving macrophages of glucose had profound implications on both ROS production and the gene expression pattern. Specifically, reducing glycolytic flux by treatment with 2-deoxy-glucose restored the expression of the negative regulators Krüppel-like factor (KLF)2 and KLF4, which inhibit inflammatory effector functions.

Conclusion: Enhanced glucose metabolism acts as an upstream regulator of inflammatory macrophage functions. ROS, produced in excess by glucose-addicted macrophages, influence the chemokine production pattern, specifically CCL18, a predominant chemokine in atherosclerotic plaque. Patients with RA and CAD share common features in macrophage differentiation towards hyperinflammtory effector cells. Such macrophages may contribute to the acceleration of CAD in RA patients.


Disclosure: T. Shirai, None; B. Schaefgen, None; B. Wallis, None; E. L. Matteson, Novartis/Sanofi/Centocor-Jansen/Celgene/Amgen/Roche/Genentech/Mesoblast/Pfizer, 2; T. L. Assimes, None; D. G. Harrison, None; J. Goronzy, None; C. M. Weyand, None.

To cite this abstract in AMA style:

Shirai T, Schaefgen B, Wallis B, Matteson EL, Assimes TL, Harrison DG, Goronzy J, Weyand CM. Enhanced Oxidant Signaling in Inflammatory Macrophages in Rheumatoid Arthritis (RA) and in Coronary Artery Disease (CAD) [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/enhanced-oxidant-signaling-in-inflammatory-macrophages-in-rheumatoid-arthritis-ra-and-in-coronary-artery-disease-cad/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/enhanced-oxidant-signaling-in-inflammatory-macrophages-in-rheumatoid-arthritis-ra-and-in-coronary-artery-disease-cad/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology